BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37002152)

  • 1. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
    Xie F; Quan R; Zhang G; Tian H; Chen Y; Yu Z; Zhang C; Liu Y; Zhu X; Wu W; Zhu X; Yang Z; Gu Q; Xiong C; Han H; Cheng Y; He J; Wu Y
    J Heart Lung Transplant; 2023 Jul; 42(7):974-984. PubMed ID: 37002152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry.
    Alonso-Gonzalez R; Lopez-Guarch CJ; Subirana-Domenech MT; Ruíz JMO; González IO; Cubero JS; Del Cerro MJ; Salvador ML; Subira LD; Gallego P; Escribano-Subias P;
    Int J Cardiol; 2015 Apr; 184():717-723. PubMed ID: 25781723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
    Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
    Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension-A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals.
    Rudienė V; Kaplerienė L; Jančauskaitė D; Meškėnė E; Palevičiūtė E; Laukytė-Slėnienė M; Gasiūnaitė D; Ramašauskaitė D; Jurevičienė E; Gumbienė L
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454315
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
    Luna-Lopez R; Segura de la Cal T; Sarnago Cebada F; Martin de Miguel I; Hinojosa W; Cruz-Utrilla A; Velazquez MT; Delgado JF; Mendoza A; Arribas Ynsaurriaga F; Escribano-Subías P
    Heart; 2024 Feb; 110(5):346-352. PubMed ID: 37903556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, goal-oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry.
    Quan R; Zhang G; Yu Z; Zhang C; Yang Z; Tian H; Yang Y; Wu W; Chen Y; Liu Y; Zhu X; Li S; Shen J; Zheng Z; Zhu X; Wang G; Wang Q; Zhou D; Ji Y; Yang T; Li W; Chen X; Qian Y; Lin Y; Gu Q; Xiong C; Shan G; He J
    Respirology; 2022 Jul; 27(7):517-528. PubMed ID: 35293069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease.
    Arshad HB; Duarte VE
    Methodist Debakey Cardiovasc J; 2021; 17(2):145-151. PubMed ID: 34326934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
    Zhang HD; Yan Y; He YY; Liu QQ; Peng FH; Yan XX; Han ZY
    Int J Cardiol; 2023 Mar; 375():29-35. PubMed ID: 36565957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.
    Duffels MG; Engelfriet PM; Berger RM; van Loon RL; Hoendermis E; Vriend JW; van der Velde ET; Bresser P; Mulder BJ
    Int J Cardiol; 2007 Aug; 120(2):198-204. PubMed ID: 17182132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Hypertension in Adults with Congenital Heart Disease.
    Goldstein SA; Krasuski RA
    Cardiol Clin; 2022 Feb; 40(1):55-67. PubMed ID: 34809917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension: closing the gap in congenital heart disease.
    Brida M; Nashat H; Gatzoulis MA
    Curr Opin Pulm Med; 2020 Sep; 26(5):422-428. PubMed ID: 32657834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features of adult patients with Eisenmenger syndrome associated with different types of congenital heart disease].
    Chen G; He JG; Liu ZH; Gu Q; Ni XH; Zhao ZH; Xiong CM
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(20):1546-9. PubMed ID: 24028720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry.
    Kaemmerer AS; Gorenflo M; Huscher D; Pittrow D; Ewert P; Pausch C; Delcroix M; Ghofrani HA; Hoeper MM; Kozlik-Feldmann R; Skride A; Stähler G; Vizza CD; Jureviciene E; Jancauskaite D; Gumbiene L; Ewert R; Dähnert I; Held M; Halank M; Skowasch D; Klose H; Wilkens H; Milger K; Jux C; Koestenberger M; Scelsi L; Brunnemer E; Hofbeck M; Ulrich S; Vonk Noordegraaf A; Lange TJ; Bruch L; Konstantinides S; Claussen M; Löffler-Ragg J; Wirtz H; Apitz C; Neidenbach R; Freilinger S; Nemes A; Opitz C; Grünig E; Rosenkranz S
    Cardiovasc Diagn Ther; 2021 Dec; 11(6):1255-1268. PubMed ID: 35070795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COngenital HeARt Disease in adult and Pulmonary Hypertension (COHARD-PH) registry: a descriptive study from single-center hospital registry of adult congenital heart disease and pulmonary hypertension in Indonesia.
    Dinarti LK; Hartopo AB; Kusuma AD; Satwiko MG; Hadwiono MR; Pradana AD; Anggrahini DW
    BMC Cardiovasc Disord; 2020 Apr; 20(1):163. PubMed ID: 32264836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.